Elan Corporation PLC (ELN)’s Response to Royalty Pharma Announcement
5/20/2013 2:10:29 PM
More...
|
Elan Corporation PLC (ELN) Spends $380 Million to Repel Royalty Pharma Bid, Eyes More Deals With $1 Billion Warchest
5/20/2013 7:33:55 AM
More...
|
Royalty Pharma Warns of Job Cuts if Elan Corporation PLC (ELN) Bid Accepted
5/6/2013 7:54:05 AM
More...
|
Elan Corporation PLC (ELN) Shareholders Approve Buyback as Royalty Pharma Fight Heats Up
4/12/2013 7:12:37 AM
More...
|
Elan Corporation PLC (ELN) Not Impressed With Royalty Pharma's $6.5 Billion Takeover Bid
2/27/2013 7:48:42 AM
More...
|
Royalty Pharma Offers $6.5 Billion for Elan Corporation PLC (ELN)
2/25/2013 8:16:17 AM
More...
|
Royalty Pharma Seeks Lower Rate on $2.72 Billion of Loans
9/25/2012 7:56:43 AM
More...
|
Royalty Pharma Buys an Interest in Fumaderm for $761 Million Cash
5/3/2012 6:49:43 AM
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) and Royalty Pharma Announce $25 Million Vosaroxin Royalty Agreement
3/30/2012 6:36:28 AM
More...
|
Nektar Therapeutics (CA) (NKTR) Announces Agreement to Sell CIMZIA® and MIRCERA® Royalties to Royalty Pharma for $124 Million
2/29/2012 7:57:48 AM
More...
|
|